These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25612178)

  • 1. Highlights of the 2014 International AIDS Conference: update from down under.
    Volberding PA
    Top Antivir Med; 2014 Dec-2015 Jan; 22(5):694-7. PubMed ID: 25612178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral Therapy for HIV Infection: When to Initiate Therapy, Which Regimen to Use, and How to Monitor Patients on Therapy.
    Johnson SC
    Top Antivir Med; 2016 Dec-2017 Jan; 23(5):161-7. PubMed ID: 27398769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.
    Bräu N
    J Antimicrob Chemother; 2005 Dec; 56(6):991-5. PubMed ID: 16308419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G; Calza L; Manfredi R; Chiodo F
    Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
    Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
    J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.
    Benson CA; Currier JS; Del Rio C; Gallant JE; Gulick RM; Marrazzo JM; Richman DD; Saag MS; Schooley RT; Volberding PA
    Top Antivir Med; 2017; 24(4):142-151. PubMed ID: 28208122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of HIV and hepatitis virus coinfection.
    Mendes-Corrêa M; Núñez M
    Expert Opin Pharmacother; 2010 Oct; 11(15):2497-516. PubMed ID: 20629586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
    Bräu N
    Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapy.
    Raboud J; Anema A; Su D; Klein MB; Zakaryan A; Swan T; Palmer A; Hosein S; Loutfy MR; Machouf N; Montaner JS; Rourke SB; Tsoukas C; Hogg RS; Cooper C;
    HIV Clin Trials; 2012; 13(2):90-102. PubMed ID: 22510356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.
    Sanmartin R; de Felipe E; Tor J; Sanvicens A; Barluenga E; Martinez E; Muga R; Jou A; Ojanguren I; López JJ; Clotet B; Tural C
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1235-43. PubMed ID: 22443303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. News on HIV-HCV Coinfection: Update From the 2015 GEHEP Conference.
    Poveda E; Wyles D; Morano L; Pineda JA; García F;
    AIDS Rev; 2015; 17(4):231-7. PubMed ID: 26616846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel.
    Volberding PA
    Top Antivir Med; 2017; 25(1):17-24. PubMed ID: 28402930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing Initial Antiretroviral Therapy: Current Recommendations for Initial Therapy and Newer or Investigational Agents.
    Gulick RM
    Top Antivir Med; 2015; 23(4):128-31. PubMed ID: 26713502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigational Antiretroviral Drugs: What is Coming Down the Pipeline.
    Gulick RM
    Top Antivir Med; 2018 Apr; 25(4):127-132. PubMed ID: 29689540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating hepatitis C in HIV-HCV coinfected patients.
    Tossing G
    Infection; 2002 Oct; 30(5):329-31. PubMed ID: 12420736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus.
    Endo T; Fujimoto K; Nishio M; Yamamoto S; Obara M; Sato N; Koike T
    J Med Virol; 2009 Jun; 81(6):979-82. PubMed ID: 19382259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of hepatitis C in a patient with advanced AIDS and decompensated cirrhosis.
    Johanson FD; Balliram DB
    AIDS Read; 2003 Oct; 13(10):494-6, 500-1. PubMed ID: 14596227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Advanced Fibrosis in the Context of Hepatitis C Virus Infection.
    Verna EC
    Top Antivir Med; 2017; 25(1):7-11. PubMed ID: 28402928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newly approved integrase inhibitors for clinical treatment of AIDS.
    Gu WG
    Biomed Pharmacother; 2014 Oct; 68(8):917-21. PubMed ID: 25451165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.